Skip to main content

Attention:

If you applied for or received your intial OMMA business license before August 30, 2019, and your renewal application has been rejected for failure to meet the 2-year/5-year residency requirements, please submit your application. 

OMMA Patient Advisory: THC-O-Acetate Confirmed

Monday, October 18, 2021

We are starting to see a rise in the number of medical marijuana products that contain THC analogs, including THC-O-acetate. This manufactured THC compound is NOT a medical marijuana product and has been shown to be very harmful when added to other THC-containing products, causing side effects such as seizures, difficulty speaking, and vomiting. 

Reports of these dangerous side effects are increasing, which is why our QA lab, Metis, is diligently monitoring for this substance and other THC analogs. Metis has confirmed the presence of this chemical compound in a concentrate by the name of Platinum OG Sugar (BA#-POG-062421).

If you’ve had negative health outcomes after using a medical marijuana product purchased from a licensed dispensary,  please immediately contact a medical provider or the Oklahoma Center for Poison and Drug Control (800-222-1222).

When purchasing a medical marijuana product from a licensed dispensary, we strongly encourage you to always ask to see the Certificates of Analysis (COAs) and examine the lab test results so you can ensure you’re taking a safe product home. If the dispensary refuses to show you the product’s COAs, we suggest you purchase product from another dispensary that will. In the event a dispensary refuses to provide you with a product’s COAs, please contact the OMMA Call Center (405-522-6662) or email OMMACompliance@ok.gov.

Last Modified on Oct 18, 2021
Back to Top